Retrospective evaluation of totally implantable venous access port devices: Early and late complications

Basit Öğe Kaydı
dc.authorid0000-0001-9081-2405
dc.authorid0000-0001-9081-2405
dc.authorscopusid14008084500
dc.authorscopusid6701472672
dc.authorscopusid10139012600
dc.authorscopusid8666331800
dc.authorscopusid56626068700
dc.authorscopusid55317577700
dc.authorwosidgur, ozcan/AAA-8847-2022
dc.authorwosidseber, selcuk/T-9539-2019
dc.authorwosidseber, selcuk e/H-3327-2017
dc.authorwosidGurkan, Selami/AAA-9006-2022
dc.contributor.authorGürkan, Selami
dc.contributor.authorSeber, Selçuk
dc.contributor.authorGür, Özcan
dc.contributor.authorYetişyiğit, Tarkan
dc.contributor.authorDonbaloğlu, Mehmet Okan
dc.contributor.authorÖzkaramanlı Gür, Demet
dc.date.accessioned2022-05-11T14:35:59Z
dc.date.available2022-05-11T14:35:59Z
dc.date.issued2015
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kalp ve Damar Cerrahisi Ana Bilim Dalı
dc.description.abstractPurpose: The role totally implantable vascular devices (TI-VAD) have an important role in providing care to cancer patients who require continuous or frequent venous access route either for their primary or supportive care treatments. This retrospective study aimed to analyze the efficacy of TIVAD and device-related complications. Methods: A total of 324 consecutive patients (185 male, 139 female, median age 56 years, mean 48 +/- 10.91; min:16, max:87) who were implanted with TIVAD between January 2012 May 2014 were included. We retrospectively assessed all TIVAD complications and focused on early and late complications. Results: A total of 324 devices were implanted successfully without major complications. The overall complication rate was 33.95% (N=110). Of them, 87(26.85%) were early and 23 (7.09%) were late complications. In total, 39 (11.23%) catheters were removed, in 8 (2.30%) patients due to complication and in 31(9.56%) due to the end of treatment. Conclusion: Most of the complications of TIVAD were early without requiring removal. Port catheters for chemotherapy are safe and well tolerated with acceptable complication rates.
dc.identifier.endpage345
dc.identifier.issn1107-0625
dc.identifier.issn2241-6293
dc.identifier.issue1en_US
dc.identifier.pmid25778336
dc.identifier.scopus2-s2.0-84928704220
dc.identifier.scopusqualityQ3
dc.identifier.startpage338
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8326
dc.identifier.volume20
dc.identifier.wosWOS:000351566500048
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorGürkan, Selami
dc.institutionauthorGür, Özcan
dc.institutionauthorYetişyiğit, Tarkan
dc.institutionauthorDonbaloğlu, Mehmet Okan
dc.language.isoen
dc.publisherImprimatur Publications
dc.relation.ispartofJournal of Buon
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectcancer
dc.subjectchemotherapy
dc.subjectcomplication
dc.subjecttotally implantable venous access device
dc.subjectSystems
dc.subjectInsertion
dc.subjectManagement
dc.subjectPlacement
dc.subjectCatheters
dc.subjectOncology
dc.subjectChildren
dc.subjectRisk
dc.titleRetrospective evaluation of totally implantable venous access port devices: Early and late complications
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8326.pdf
Boyut:
633.52 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu